Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
40 hedge funds and large institutions have $35.8M invested in Alimera Sciences in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 5 closing their positions.
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
2% less funds holding
Funds holding: 41 → 40 (-1)
17% less capital invested
Capital invested by funds: $42.9M → $35.8M (-$7.14M)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
88% less call options, than puts
Call options by funds: $1K | Put options by funds: $8K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.1M |
| 2 |
AC
Armistice Capital
New York
|
+$147K |
| 3 |
Renaissance Technologies
New York
|
+$69.3K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$49.9K |
| 5 |
SIM
Spark Investment Management
New York
|
+$39.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$319K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$137K |
| 3 |
VF
Virtu Financial
New York
|
-$46K |
| 4 |
Millennium Management
New York
|
-$22K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17.5K |
ALIM Hedge Fund Activity: Q1 2018 in Review
40 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2018, worth a combined $35.8M — down 17% from $42.9M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ALIM and 4 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 11 added.
The largest buyer was Stonepine Capital Management, adding an estimated $3.1M. The largest seller was JW Asset Management, cutting an estimated $319K.
- 40 institutional investors held Alimera Sciences (ALIM) as of Q1 2018, down from 41 in Q4 2017.
- Funds reported $35.8M of Alimera Sciences stock for Q1 2018, down 17% quarter-over-quarter.
- 4 funds opened new Alimera Sciences positions in Q1 2018 and 5 closed out, a net change of -1 holder.
- The largest Alimera Sciences buyer in Q1 2018 was Stonepine Capital Management, an estimated $3.1M added.
- The largest Alimera Sciences seller in Q1 2018 was JW Asset Management, an estimated $319K sold.
Based on aggregated 13F filings for Q1 2018.